Inventory

Inventories consist of raw materials and work-in-process intended for use in the manufacture of LAVIV, which was approved by the FDA in 2011 for the improvement of nasolabial fold wrinkles in adults. However, raw materials may be used for clinical trials and are charged to research and development (R&D) expense when consumed.

Inventories consisted of the following as of:



($ in thousands)	March 31, 2016		December 31, 2015
($ in thousands)	March 31, 2016		December 31, 2015
Raw materials (LAVIV and product candidates)	$	276	$	338
Work in process (LAVIV)	199		144
Total Inventory	$	475	$	482